• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    ASP Isotopes Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    6/4/25 10:27:08 AM ET
    $ASPI
    Major Chemicals
    Industrials
    Get the next $ASPI alert in real time by email
    aspi_8k.htm
    0001921865false00019218652025-06-042025-06-04iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): June 4, 2025

     

    ASP Isotopes Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware

     

    001-41555

     

    87-2618235

    (State or other jurisdiction of

    incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    601 Pennsylvania Avenue NW

    South Building, Suite 900

    Washington, DC

     

    20004

    (Address of principal executive offices)

     

    (Zip Code)

     

    Registrant’s telephone number, including area code: (202) 756-2245

     

    Not Applicable

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading symbol(s)

     

    Name of each exchange on which registered

    Common Stock, par value $0.01

     

    ASPI

     

    The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

     

     

     

     

    Item 8.01. Other Events.

     

    On June 4, 2025, ASP Isotopes Inc. (the “Company”) issued a press release announcing that the Company has entered into a supply agreement with Isotopia Molecular Imaging Ltd. related to the supply of enriched Gadolinium-160.  Also on June 4, 2025, the Company issued a press release announcing that the Company will host an investor access event in South Africa from June 16-18, 2025.  A copy of each of the press releases is attached to this Current Report on Form 8-K as Exhibits 99.1 and 99.2 and are incorporated herein by reference, other than the fifth and sixth paragraphs of the press release attached as Exhibit 99.1.

     

    Item 9.01. Financial Statements and Exhibits.

     

    Exhibit No.

     

    Description

    99.1

     

    Press Release, dated June 4, 2025, of ASP Isotopes Inc. announcing supply agreement with Isotopia Molecular Imaging Ltd. for enriched Gadolinium-160.

    99.2

     

    Press Release, dated June 4, 2025, of ASP Isotopes Inc. announcing investor access event in South Africa from June 16-18, 2025.

    104

     

    Cover Page Interactive Date File (embedded within the Inline XBRL document)

     

     
    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

    ASP ISOTOPES INC.

     

     

     

     

    Date: June 4, 2025

    By:

    /s/ Paul Mann

     

     

    Name:

    Paul Mann

     

     

    Title:

    Chief Executive Officer

     

     

     
    3

     

    Get the next $ASPI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASPI

    DatePrice TargetRatingAnalyst
    10/4/2024$4.50Buy
    Canaccord Genuity
    12/5/2023$3.25Buy
    H.C. Wainwright
    More analyst ratings